Lifecode

The deal, which comes about three months after Lifecode's acquisition by MedGenome, marks Vela's first foray into the genomic data interpretation market.

The acquisition will give India's MedGenome access to a CLIA-certified and CAP-accredited laboratory in the Bay Area so that it can expand its operations in the US.

The previously undisclosed Series A Round financing was led by Sequoia Capital, Mayo Clinic, and Mayo Ventures. 

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.